EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C16H21NO3 |
| Net Charge | 0 |
| Average Mass | 275.348 |
| Monoisotopic Mass | 275.15214 |
| SMILES | CCCC(C(=O)c1ccc2c(c1)OCO2)N1CCCC1 |
| InChI | InChI=1S/C16H21NO3/c1-2-5-13(17-8-3-4-9-17)16(18)12-6-7-14-15(10-12)20-11-19-14/h6-7,10,13H,2-5,8-9,11H2,1H3 |
| InChIKey | SYHGEUNFJIGTRX-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | dopamine uptake inhibitor A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake. adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. |
| Applications: | dopamine uptake inhibitor A dopaminergic agent that blocks the transport of dopamine into axon terminals or into storage vesicles within terminals. Most of the adrenergic uptake inhibitors also inhibit dopamine uptake. adrenergic uptake inhibitor Adrenergic uptake inhibitors are drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. psychotropic drug A loosely defined grouping of drugs that have effects on psychological function. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 3,4-methylenedioxypyrovalerone (CHEBI:233286) has role adrenergic uptake inhibitor (CHEBI:35640) |
| 3,4-methylenedioxypyrovalerone (CHEBI:233286) has role dopamine uptake inhibitor (CHEBI:51039) |
| 3,4-methylenedioxypyrovalerone (CHEBI:233286) has role psychotropic drug (CHEBI:35471) |
| 3,4-methylenedioxypyrovalerone (CHEBI:233286) is a organic molecular entity (CHEBI:50860) |
| IUPAC Name |
|---|
| 1-(1,3-benzodioxol-5-yl)-2-pyrrolidin-1-ylpentan-1-one |
| Synonym | Source |
|---|---|
| MDPV | SUBMITTER |
| Manual Xrefs | Databases |
|---|---|
| HMDB0254640 | HMDB |
| C22808 | KEGG COMPOUND |
| https://en.wikipedia.org/wiki/Methylenedioxypyrovalerone | Wikipedia |
| Registry Numbers | Sources |
|---|---|
| CAS:687603-66-3 | SUBMITTER |
| Citations |
|---|